Ajooni Biotech Limited Stock EBITDA
| AJOONI Stock | 7.79 0.37 4.99% |
Ajooni Biotech Limited fundamentals help investors to digest information that contributes to Ajooni Biotech's financial success or failures. It also enables traders to predict the movement of Ajooni Stock. The fundamental analysis module provides a way to measure Ajooni Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ajooni Biotech stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 44.3 M | 46.5 M |
Ajooni | EBITDA |
Ajooni Biotech Limited Company EBITDA Analysis
Ajooni Biotech's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Ajooni Biotech EBITDA | 44.27 M |
Most of Ajooni Biotech's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ajooni Biotech Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Ajooni Ebitda
Ebitda |
|
According to the company disclosure, Ajooni Biotech Limited reported earnings before interest,tax, depreciation and amortization of 44.27 M. This is 97.08% lower than that of the Food Products sector and 95.47% lower than that of the Consumer Staples industry. The ebitda for all India stocks is 98.86% higher than that of the company.
Ajooni EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ajooni Biotech's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ajooni Biotech could also be used in its relative valuation, which is a method of valuing Ajooni Biotech by comparing valuation metrics of similar companies.Ajooni Biotech is currently under evaluation in ebitda category among its peers.
Ajooni Fundamentals
| Return On Equity | 0.0354 | ||||
| Return On Asset | 0.0139 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 754.71 M | ||||
| Shares Outstanding | 99.37 M | ||||
| Price To Book | 1.73 X | ||||
| Price To Sales | 0.91 X | ||||
| Revenue | 800.01 M | ||||
| Gross Profit | 87.45 M | ||||
| EBITDA | 44.27 M | ||||
| Net Income | 21.61 M | ||||
| Total Debt | 21.68 M | ||||
| Book Value Per Share | 4.88 X | ||||
| Cash Flow From Operations | (39.52 M) | ||||
| Earnings Per Share | 0.22 X | ||||
| Number Of Employees | 109 | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 774.1 M | ||||
| Total Asset | 475.2 M | ||||
| Retained Earnings | 86.91 M | ||||
| Working Capital | 194.62 M | ||||
| Net Asset | 475.2 M |
About Ajooni Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ajooni Biotech Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ajooni Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ajooni Biotech Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ajooni Stock
Ajooni Biotech financial ratios help investors to determine whether Ajooni Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajooni with respect to the benefits of owning Ajooni Biotech security.